CARL Stock Price Today (October 2026) — Carlsmed, Inc. Analysis & Key Metrics 2026-10-23
Carlsmed, Inc. (CARL) is trading at $14.53, down 0.55% today (as of October 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $19.40 (33.5% upside).
- Volatility is high (44.88% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (56.70% YoY) alongside competitive pressures in the Health Information Services space.
CARL Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Carlsmed, Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $329.40M
P/E Ratio
Forward P/E: N/A
Revenue Growth
Year over Year
Analyst Target
+33.5% upside potential
Key Investor Questions About CARL
What investors need to know before buying
Based on current market data, CARL presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 53.28)
- Fundamentals say: Looking solid (debt and growth supportive)
CARL's growth trajectory depends on its ability to expand within the Health Information Services sector while managing margin pressures.
- Future growth will depend on performance in core Health Information Services operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for CARL investors include debt exposure and competitive dynamics in the Health Information Services industry.
- $21.92M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Health Information Services.
52-Week Trading Range
Over the past year, CARL stock traded between $8.50 and $17.23 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 44.88% annualized volatility and β=0.95, the stock exhibits moderate correlation to market moves—making CARL suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
Lower institutional support combined with high short selling points to negative sentiment.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
Carlsmed names new CFO
Carlsmed Names Richard Heppenstall CFO; Company Reiterates Fiscal 2026 Revenue Guidance
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Latest TickZen Insights
All insights →No TickZen article on CARL yet. Our newest analysis:
Explore More Analysis for CARL
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Nov 5, 2026 (after the close, usually)
Frequently Asked Questions
Common investor questions about Carlsmed, Inc.
Carlsmed, Inc. (CARL) is currently trading at $14.53. The RSI (14-day) is at 53.3, indicating neutral territory. Wall Street analysts have a consensus "strong_buy" recommendation. The mean analyst price target of $19.40 implies 33.5% upside from current levels. Volatility is high at 44.9% annualized, meaning significant price swings are common. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Carlsmed, Inc. (CARL): The trailing P/E ratio is not available (the company may not be profitable). Price-to-Book is 4.70. Price-to-Sales is 6.27. Valuation should be compared to Health Information Services industry peers for context, as different sectors trade at different multiples.
Based on 5 analysts covering CARL, the consensus price target is $19.40. This represents a 33.5% upside from the current price of $14.53. The range spans from a low target of $17.00 to a high target of $24.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "strong_buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Carlsmed, Inc. (CARL) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Carlsmed, Inc. (CARL) investors include: 1. High volatility (44.9% annualized)—the stock can experience significant daily price swings. 2. The company is not currently profitable on a trailing basis, which creates earnings uncertainty. 3. Elevated short interest (10.3% of float) suggests significant bearish sentiment. 4. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 5. Health Information Services sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Carlsmed, Inc.'s (CARL) current debt and financial health profile: Total debt stands at $21.92M. The debt-to-equity ratio is 0.26x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 8.84, indicating strong short-term liquidity. The quick ratio is 8.31. The company holds $89.22M in cash and equivalents. Free cash flow is negative at -$35.67M, which could limit the company's ability to manage debt obligations.